Mycobacterium tuberculosis, the causative agent of tuberculosis, remains the leading cause of infectious disease worldwide, affecting approximately a quarter of the globe’s population. Treatment of infections is problematic… read more.
Patients are 20% less likely to die of sepsis because a new AI system developed at Johns Hopkins University catches symptoms hours earlier than traditional methods, an extensive… read more.
Among hospitalized COVID-19 patients, treatment with convalescent plasma does not improve potential for survival or recovery, researchers reported. Their findings were published on July 7, 2022 in CHEST…. read more.
A novel long-term study of how vaccine-related fears influence flu shot outcomes has found that these fears not only reduce vaccination, but also fuel symptoms of dizziness and… read more.
Researchers have warned the long-term effects of coronavirus will have a significant impact on the UK workforce for some time. Of those who have been infected with Covid-19,… read more.
Existing gaps and serious limitations concerning the information in vaccine product labels makes it challenging for healthcare providers to know when to recommend vaccination to pregnant women. A… read more.
People with hematologic malignancies—or blood cancers including leukemia, lymphoma, and multiple myeloma—have an impaired immune system due to their disease and its treatment, putting them at risk of… read more.
Researchers report that two years after diagnosis half of patients hospitalized with COVID-19 have at least one ongoing symptom. The findings appeared in on May 11, 2022 in… read more.
Around one in 500 men could be carrying an extra X or Y chromosome — most of them unaware — putting them at increased risk of diseases such… read more.
Surface sampling for SARS-CoV-2 RNA has shown promise to detect the exposure of environments to infected individuals shedding the virus who would not otherwise be detected. Now a… read more.
China’s medical products regulator has given conditional approval for Pfizer’s COVID-19 drug Paxlovid, making it the first oral pill specifically developed to treat the disease cleared in the… read more.
Researchers report that hormone replacement therapy is associated with a reduction in COVID-19 mortality. Their findings appeared on May 22, 2022 in Family Practice. “This study supports the… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
